BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 37369519)

  • 21. Yttrium-90 radioembolization for unresectable metastatic neuroendocrine liver tumor: A systematic review.
    Jia Z; Wang W
    Eur J Radiol; 2018 Mar; 100():23-29. PubMed ID: 29496075
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transcatheter arterial embolization of hypervascular tumors with HepaSphere: prospective multicenter open label clinical trial of microspheres in Japan.
    Hiraki T; Koizumi J; Arai Y; Sakurai Y; Kumada H; Nambu Y; Hori S
    Jpn J Radiol; 2015 Aug; 33(8):479-86. PubMed ID: 26111877
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologically-Proven Efficacy of Bland Embolization in a Patient with Net Liver Metastasis.
    Monfardini L; Varano GM; Foà R; Della Vigna P; Bonomo G; Bertani E; Guerini-Rocco E; Spada F; Orsi F
    Cardiovasc Intervent Radiol; 2016 Jun; 39(6):948-52. PubMed ID: 26714693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Polyethylene Glycol Epirubicin-Loaded Transcatheter Arterial Chemoembolization Procedures Utilizing a Combined Approach with 100 and 200 μm Microspheres: A Promising Alternative to Current Standards.
    Lucatelli P; Argirò R; De Rubeis G; Rocco B; Corradini SG; Corona M; Nardis PG; Saba L; Mennini G; Fiorentino F; Corsi A; Catalano C; Bezzi M
    J Vasc Interv Radiol; 2019 Mar; 30(3):305-313. PubMed ID: 30713031
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Particle embolization of recurrent hepatocellular carcinoma after hepatectomy.
    Covey AM; Maluccio MA; Schubert J; BenPorat L; Brody LA; Sofocleous CT; Getrajdman GI; Fong Y; Brown KT
    Cancer; 2006 May; 106(10):2181-9. PubMed ID: 16596622
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of response to radio-embolization (TheraSphere®) treatment of neuroendocrine liver metastasis.
    Shaheen M; Hassanain M; Aljiffry M; Cabrera T; Chaudhury P; Simoneau E; Kongkaewpaisarn N; Salman A; Rivera J; Jamal M; Lisbona R; Khankan A; Valenti D; Metrakos P
    HPB (Oxford); 2012 Jan; 14(1):60-6. PubMed ID: 22151453
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 90Y glass microspheres for the treatment of unresectable metastatic liver disease from chemotherapy-refractory gastrointestinal cancers: a pilot study.
    Fidelman N; Kerlan RK; Hawkins RA; Taylor AG; Kohi MP; Kolli KP; Bergsland EK; Kelley RK; Ko AH; Korn WM; McWhirter RM; Luan J; Venook AP
    J Gastrointest Cancer; 2014 Jun; 45(2):168-80. PubMed ID: 24448917
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of the survival and tolerability of radioembolization in elderly vs. younger patients with unresectable hepatocellular carcinoma.
    Golfieri R; Bilbao JI; Carpanese L; Cianni R; Gasparini D; Ezziddin S; Paprottka PM; Fiore F; Cappelli A; Rodriguez M; Ettorre GM; Saltarelli A; Geatti O; Ahmadzadehfar H; Haug AR; Izzo F; Giampalma E; Sangro B; Pizzi G; Notarianni E; Vit A; Wilhelm K; Jakobs TF; Lastoria S;
    J Hepatol; 2013 Oct; 59(4):753-61. PubMed ID: 23707371
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary treatment of painful varicocoele through percutaneous retrograde embolization with fibred coils.
    Puche-Sanz I; Flores-Martín JF; Vázquez-Alonso F; Pardo-Moreno PL; Cózar-Olmo JM
    Andrology; 2014 Sep; 2(5):716-20. PubMed ID: 25073877
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioembolization for unresectable neuroendocrine hepatic metastases using resin 90Y-microspheres: early results in 148 patients.
    Kennedy AS; Dezarn WA; McNeillie P; Coldwell D; Nutting C; Carter D; Murthy R; Rose S; Warner RR; Liu D; Palmedo H; Overton C; Jones B; Salem R
    Am J Clin Oncol; 2008 Jun; 31(3):271-9. PubMed ID: 18525307
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Transarterial Radioembolization Treatment of Pancreatic Cancer Patients with Liver-Dominant Metastatic Disease Using Yttrium-90 Glass Microspheres: A Single-Institution Retrospective Study.
    Kayaleh R; Krzyston H; Rishi A; Naziri J; Frakes J; Choi J; El-Haddad G; Parikh N; Sweeney J; Kis B
    J Vasc Interv Radiol; 2020 Jul; 31(7):1060-1068. PubMed ID: 32534978
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bland embolization in the treatment of hepatic adenomas: preliminary experience.
    Deodhar A; Brody LA; Covey AM; Brown KT; Getrajdman GI
    J Vasc Interv Radiol; 2011 Jun; 22(6):795-9; quiz 800. PubMed ID: 21616432
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Initial study of radiological and clinical efficacy radioembolization using 188Re-human serum albumin (HSA) microspheres in patients with progressive, unresectable primary or secondary liver cancers.
    Nowicki ML; Cwikla JB; Sankowski AJ; Shcherbinin S; Grimmes J; Celler A; Buscombe JR; Bator A; Pech M; Mikołajczak R; Pawlak D
    Med Sci Monit; 2014 Aug; 20():1353-62. PubMed ID: 25086245
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Embolization of parasitized extrahepatic arteries to reestablish intrahepatic arterial supply to tumors before yttrium-90 radioembolization.
    Abdelmaksoud MH; Louie JD; Kothary N; Hwang GL; Kuo WT; Hofmann LV; Hovsepian DM; Sze DY
    J Vasc Interv Radiol; 2011 Oct; 22(10):1355-62. PubMed ID: 21961979
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Sarcopenia as a predictor of survival in patients undergoing bland transarterial embolization for unresectable hepatocellular carcinoma.
    Lanza E; Masetti C; Messana G; Muglia R; Pugliese N; Ceriani R; Lleo de Nalda A; Rimassa L; Torzilli G; Poretti D; D'Antuono F; Politi LS; Pedicini V; Aghemo A;
    PLoS One; 2020; 15(6):e0232371. PubMed ID: 32555707
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Survival benefit of radioembolization for inoperable hepatocellular carcinoma using yttrium-90 microspheres.
    Kwok PC; Leung KC; Cheung MT; Lam TW; Szeto LT; Chou SQ; Chia NH; Tong CM; Yuen PK; Cheung CH; Law CK
    J Gastroenterol Hepatol; 2014 Nov; 29(11):1897-904. PubMed ID: 24734957
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effectiveness and safety of doxorubicin loaded beads in hepatocellular carcinoma.
    Muros-Ortega M; Díaz-Carrasco MS; Capel A; Calleja MÁ; Martínez F
    Int J Clin Pharm; 2013 Dec; 35(6):1105-12. PubMed ID: 23928684
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of yttrium-90 microspheres in patients with advanced hepatocellular carcinoma and portal vein thrombosis.
    Tsai AL; Burke CT; Kennedy AS; Moore DT; Mauro MA; Dixon RD; Stavas JM; Bernard SA; Khandani AH; O'Neil BH
    J Vasc Interv Radiol; 2010 Sep; 21(9):1377-84. PubMed ID: 20691606
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimizing the treatment of liver metastases from uveal melanomas with transarterial chemoembolization using melphalan and calibrated microspheres.
    Carle X; Gastaud L; Salleron J; Tardy MP; Caujolle JP; Thyss A; Thariat J; Chevallier P
    Bull Cancer; 2020 Dec; 107(12):1274-1283. PubMed ID: 33183739
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Efficacy of Radioembolization with
    Prince JF; van den Bosch MAAJ; Nijsen JFW; Smits MLJ; van den Hoven AF; Nikolakopoulos S; Wessels FJ; Bruijnen RCG; Braat MNGJA; Zonnenberg BA; Lam MGEH
    J Nucl Med; 2018 Apr; 59(4):582-588. PubMed ID: 28916623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.